Botox Warning Issued by FDA After Cases of Rare Disease Identified

newsweek.com/botox-warning-fda-cases-rare-disease-botulism-10999636

The U.S. Food and Drug Administration (FDA) is warning companies to stop marketing unapproved Botox products after reports of a rare but serious illness linked to botulism.
Why It Matters
Botulinum toxin, commonly called Botox, is used to temporarily reduce wrinkles by paralyzing facial…

This story appeared on newsweek.com, 2025-11-05 21:01:50.
The Entire Business World on a Single Page. Free to Use →